| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. | VP, Finance and Controller | Common Stock | 46,359 | $402,396 | $8.68 | 20 Dec 2025 | Direct |
| 4D Molecular Therapeutics, Inc. | VP, Finance and Controller | Restricted Stock Units | 3,308 | 20 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics, Inc. | 20 Dec 2025 | 6 | -$3,377 | 4 | VP, Finance and Controller | 23 Dec 2025, 21:05 |
| FDMT | 4D Molecular Therapeutics, Inc. | 30 Sep 2025 | 0 | $0 | 3 | VP, Finance and Controller | 10 Oct 2025, 21:04 |